secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0001628280-23-002206
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo Therapeutics prices $15M public offering of common stock and warrants
---------------------------------------------------------------------------

- Offering of 3.77M shares and warrants to purchase 3.77M shares at $3.98 combined price.
- Gross proceeds approx. $15M before expenses; warrants exercisable for one year at $5.00/share.
- Expected to close Feb 7, 2023; SVB Securities and RBC Capital Markets joint bookrunners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023002206/0001628280-23-002206-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023002206/avtx-20230202.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-002206

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer